Back to News
Market Impact: 0.25
Aquestive Therapeutics (AQST) Reports Q3 Loss, Misses Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & Biotech
Aquestive Therapeutics reported a quarterly loss of $0.13 per share, 3 cents wider than the Zacks Consensus Estimate loss of $0.10. The loss narrowed from $0.14 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
AQST-0.35
More News
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- AMD rides data center riches to ‘largest and most profitable’ quarter in history
- ‘Lawyer up’: Democrats take the House, and warn Trump’s family businesses are first in line for subpoenas
- AMD’s OpenAI, Meta chip deals trigger $1 billion quarterly charge
- AMD forecasts quarterly revenue above estimates as data-center revenue hits record
- Eaton's strong quarter should mark a bottom for shares of the AI buildout winner